Dharti Proteins Limited (formerly Devika Proteins Limited) has scheduled a board meeting for March 18, 2026, to review and approve its third quarter financial performance for FY 2025-2026. The announcement was made through a formal communication to BSE Limited on March 13, 2026, in compliance with regulatory requirements.

Board Meeting Details

The upcoming board meeting represents the fourth board meeting of FY 2025-2026 for the Ahmedabad-based company. The meeting has been scheduled to address key financial matters and ensure timely disclosure of quarterly performance.

Key Agenda Items

The board meeting will focus on two primary matters. The directors will consider, discuss and approve the unaudited standalone financial results of the company for the third quarter and nine-months ended December 31, 2025. Additionally, the board will take on record the Limited Review Report accompanying these financial results.

The meeting agenda also includes provisions for considering any other matter with the permission of the chair, allowing flexibility for additional business items that may require board attention.

Regulatory Compliance

The announcement was made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, demonstrating the company's commitment to maintaining transparency with stakeholders and adhering to prescribed disclosure timelines.

The communication was signed by Twinkle Bipinchandra Gajjar, Company Secretary and Compliance Officer, ensuring proper authorization and compliance with corporate governance requirements.